~nytimes-most-popular | Bookmarks (6)

Many people in the United States are taking five or more prescription drugs. That can lead to serious complications.

A number of new tech companies want to solve the opioid crisis with algorithms. It’s a flawed and potentially harmful proposition.

Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.

The hacking shut down the nation’s biggest health care payment system, causing financial chaos that affected a broad spectrum ranging from large hospitals to single-doctor practices.

Federal law set caps on some spending for seniors who are enrolled in Part D prescription drug plans. Those paying for high-cost medicines will benefit.